8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 8 of 8 clinical reviews.
A prescriber-level guide to recognizing, grading, and managing adverse events from finasteride and dutasteride, with dosing tables, monitoring schedules, and evidence-based mitigation strategies.
A prescriber- and pharmacist-level guide to 5-α reductase inhibitor drug class review, coding, prior authorization strategy, and step-therapy navigation for finasteride and dutasteride.
Clinical monograph covering the 5-α reductase inhibitor drug class, including finasteride and dutasteride. Mechanism, pharmacokinetics, landmark trials, dosing, adverse effects, and prescribing considerations for BPH and androgenetic alopecia.
Complete DDI table for finasteride and dutasteride, with mechanism-based interaction data, prescribing guidance, and clinical pearls at MD/PharmD level.
Complete clinical reference for 5-α reductase inhibitors (finasteride, dutasteride): mechanism, indications, dosing, monitoring bundle, adverse effects, drug interactions, and prescribing pearls at MD/PharmD level.
A prescriber-level review of 5-α reductase inhibitors (finasteride, dutasteride) across special populations: pregnancy, pediatrics, renal impairment, hepatic impairment, elderly patients, and more. Includes dosing guidance, safety data, and guideline citations.
A prescriber-level guide to finasteride vs. Dutasteride: mechanism, isoenzyme coverage, approved indications, dosing, side-effect profiles, and evidence-based selection criteria for BPH and androgenetic alopecia.
A clinical reference for prescribers and pharmacists covering finasteride and dutasteride dosing, titration strategies, tapering protocols, and evidence-based algorithms for BPH and androgenic alopecia.